JP2001211895A - Method of producing physiologically active peptide - Google Patents
Method of producing physiologically active peptideInfo
- Publication number
- JP2001211895A JP2001211895A JP2000027588A JP2000027588A JP2001211895A JP 2001211895 A JP2001211895 A JP 2001211895A JP 2000027588 A JP2000027588 A JP 2000027588A JP 2000027588 A JP2000027588 A JP 2000027588A JP 2001211895 A JP2001211895 A JP 2001211895A
- Authority
- JP
- Japan
- Prior art keywords
- angiotensin
- oligopeptide
- free radical
- converting enzyme
- active oxygen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title description 11
- 108090000765 processed proteins & peptides Proteins 0.000 title description 11
- 241000251468 Actinopterygii Species 0.000 claims abstract description 48
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 48
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 48
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 41
- 239000001301 oxygen Substances 0.000 claims abstract description 41
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 claims abstract description 40
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 claims abstract description 40
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 40
- 102000008186 Collagen Human genes 0.000 claims abstract description 29
- 108010035532 Collagen Proteins 0.000 claims abstract description 29
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000011575 calcium Substances 0.000 claims abstract description 25
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 25
- 229910052586 apatite Inorganic materials 0.000 claims abstract description 23
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 claims abstract description 23
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 22
- 229920001436 collagen Polymers 0.000 claims abstract description 22
- 238000004519 manufacturing process Methods 0.000 claims abstract description 20
- 239000000243 solution Substances 0.000 claims abstract description 20
- 108091005804 Peptidases Proteins 0.000 claims abstract description 19
- 239000004365 Protease Substances 0.000 claims abstract description 19
- 102000011782 Keratins Human genes 0.000 claims abstract description 18
- 108010076876 Keratins Proteins 0.000 claims abstract description 18
- 239000013078 crystal Substances 0.000 claims abstract description 18
- 230000000694 effects Effects 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000002253 acid Substances 0.000 claims abstract description 8
- 210000003746 feather Anatomy 0.000 claims abstract description 8
- 235000012054 meals Nutrition 0.000 claims abstract description 8
- 210000000003 hoof Anatomy 0.000 claims abstract description 7
- 239000012670 alkaline solution Substances 0.000 claims abstract description 6
- 210000004209 hair Anatomy 0.000 claims abstract description 6
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract 4
- 230000007760 free radical scavenging Effects 0.000 claims description 36
- 230000002401 inhibitory effect Effects 0.000 claims description 36
- 244000144972 livestock Species 0.000 claims description 30
- 108091005658 Basic proteases Proteins 0.000 claims description 15
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 108090000790 Enzymes Proteins 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 7
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 7
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 239000002244 precipitate Substances 0.000 claims description 6
- 150000003254 radicals Chemical class 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 208000024891 symptom Diseases 0.000 claims description 5
- 238000005238 degreasing Methods 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 4
- 241001037822 Bacillus bacterium Species 0.000 claims description 3
- 206010020772 Hypertension Diseases 0.000 claims description 3
- 235000013376 functional food Nutrition 0.000 claims description 3
- 230000003449 preventive effect Effects 0.000 claims description 3
- 102400000344 Angiotensin-1 Human genes 0.000 claims description 2
- 101800000734 Angiotensin-1 Proteins 0.000 claims description 2
- 239000003929 acidic solution Substances 0.000 claims description 2
- ORWYRWWVDCYOMK-HBZPZAIKSA-N angiotensin I Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 ORWYRWWVDCYOMK-HBZPZAIKSA-N 0.000 claims description 2
- 230000002000 scavenging effect Effects 0.000 claims 1
- 235000019688 fish Nutrition 0.000 abstract description 41
- 241000193830 Bacillus <bacterium> Species 0.000 abstract description 11
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 5
- 239000003513 alkali Substances 0.000 abstract description 3
- 235000013402 health food Nutrition 0.000 abstract description 3
- 238000005406 washing Methods 0.000 abstract description 2
- 241001465754 Metazoa Species 0.000 abstract 4
- 238000003379 elimination reaction Methods 0.000 abstract 2
- 230000005764 inhibitory process Effects 0.000 abstract 2
- 230000008021 deposition Effects 0.000 abstract 1
- 230000008030 elimination Effects 0.000 abstract 1
- -1 oxygen free radical Chemical class 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 15
- 102000004169 proteins and genes Human genes 0.000 description 15
- 108090000623 proteins and genes Proteins 0.000 description 15
- 239000000126 substance Substances 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 239000007787 solid Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 239000001506 calcium phosphate Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 5
- 241000228212 Aspergillus Species 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 229910000389 calcium phosphate Inorganic materials 0.000 description 4
- 235000011010 calcium phosphates Nutrition 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000005541 ACE inhibitor Substances 0.000 description 2
- 108091005508 Acid proteases Proteins 0.000 description 2
- 102000011632 Caseins Human genes 0.000 description 2
- 108010076119 Caseins Proteins 0.000 description 2
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 2
- 239000002374 bone meal Substances 0.000 description 2
- 229940036811 bone meal Drugs 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 108010003855 mesentericopeptidase Proteins 0.000 description 2
- 108010020132 microbial serine proteinases Proteins 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 235000015277 pork Nutrition 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- 101100454433 Biomphalaria glabrata BG01 gene Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000555825 Clupeidae Species 0.000 description 1
- 102100032768 Complement receptor type 2 Human genes 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 1
- 101000941929 Homo sapiens Complement receptor type 2 Proteins 0.000 description 1
- AXVIGSRGTMNSJU-YESZJQIVSA-N Leu-Tyr-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@@H]2C(=O)O)N AXVIGSRGTMNSJU-YESZJQIVSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 241000269851 Sarda sarda Species 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 108010056079 Subtilisins Proteins 0.000 description 1
- 102000005158 Subtilisins Human genes 0.000 description 1
- DOFAQXCYFQKSHT-SRVKXCTJSA-N Val-Pro-Pro Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DOFAQXCYFQKSHT-SRVKXCTJSA-N 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000008380 degradant Substances 0.000 description 1
- 238000005115 demineralization Methods 0.000 description 1
- 230000002328 demineralizing effect Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 229940030275 epigallocatechin gallate Drugs 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000012046 side dish Nutrition 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 108010015385 valyl-prolyl-proline Proteins 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、活性酸素フリーラ
ジカル消去活性及びアンジオテンシンI変換酵素阻害作
用を有する家畜又は魚残査由来のオリゴペプチド及びそ
の製造法や、魚類鱗並びに家畜骨及び魚骨由来のカルシ
ウムアパタイトを主成分とする白色結晶の製造法に関す
る。TECHNICAL FIELD The present invention relates to an oligopeptide derived from livestock or fish residue having an active oxygen free radical scavenging activity and angiotensin I converting enzyme inhibitory activity, a method for producing the same, a fish scale, and a livestock bone and fish bone. The present invention relates to a method for producing white crystals containing calcium apatite as a main component.
【0002】[0002]
【従来の技術】活性酸素フリーラジカルは種々の病気、
ガン、老化など人の健康に関するあらゆる事柄に関与す
ることが報告されている。そのため、ポリフェノールな
どのラジカル消去物質に大きな関心が寄せられている。
例えば、特開平6−145062号公報には、動脈硬化
等の抑制に有用なエピガロカテキンガレートを含む緑茶
抽出物とカロチノイド色素を含有する活性酸素フリーラ
ジカル消去剤が記載されている。しかし、オリゴペプチ
ドのラジカル消去活性に着目した食品素材は知られてい
ない。2. Description of the Related Art Reactive oxygen free radicals cause various diseases,
It has been reported to be involved in everything related to human health, such as cancer and aging. For this reason, radical scavengers such as polyphenols are of great interest.
For example, Japanese Patent Application Laid-Open No. 6-145062 describes an active oxygen free radical scavenger containing a green tea extract containing epigallocatechin gallate useful for suppressing arteriosclerosis and the like, and a carotenoid pigment. However, no food material focusing on the radical scavenging activity of oligopeptides is known.
【0003】最近、アンジオテンシンI変換酵素阻害物
質は、心不全の治療薬など、血圧降下剤以外の用途でも
注目を集めている。従来、アンジオテンシンI変換酵素
阻害物質としては、蛇毒中のペプチドをはじめとして天
然物や合成物が多数報告されている。例えば、牛乳カゼ
イン中で乳酸菌等を培養することにより産出するIle-Pr
o-Pro、 Val-Pro-Proのアミノ酸配列を有するトリペプ
チドを分離、精製する方法(特開平6−197786号
公報)や、鰹節等の魚肉を酵素分解することにより得ら
れるLeu-Tyr-Pro骨格を持つトリペプチドがアンジオテ
ンシンI変換酵素阻害作用を有すること(特開平4−1
39195号公報)や、乳カゼイン、大豆タンパク質な
どのプロテアーゼ分解物がアンジオテンシンI変換酵素
阻害作用を有すること(特開平8−283173号公
報)が報告されている。しかし、これらの天然由来のペ
プチドはいずれも苦味が強く食品添加物とするには問題
があったり、また、合成ペプチドは副作用の恐れがあり
安全性に大きな注意を払わねばならないという問題があ
った。[0003] Recently, angiotensin I converting enzyme inhibitors have attracted attention for uses other than antihypertensive agents, such as therapeutic agents for heart failure. Conventionally, as angiotensin I converting enzyme inhibitors, many natural products and synthetic products have been reported, including peptides in snake venom. For example, Ile-Pr produced by culturing lactic acid bacteria in milk casein
A method for separating and purifying a tripeptide having an amino acid sequence of o-Pro and Val-Pro-Pro (Japanese Patent Laid-Open No. Hei 6-197786), and Leu-Tyr-Pro obtained by enzymatically decomposing fish meat such as bonito. That the tripeptide having a skeleton has an angiotensin I converting enzyme inhibitory action
39195), and that protease degradants such as milk casein and soy protein have an angiotensin I converting enzyme inhibitory action (Japanese Patent Application Laid-Open No. 8-283173). However, all of these naturally occurring peptides have a strong bitter taste and are problematic in making them food additives, and synthetic peptides have the problem that side effects may occur and great attention must be paid to safety. .
【0004】また、カルシウムは日本人の食生活におい
て不足することが指摘されており、特に骨そしょう症と
の関係から若い女性におけるカルシウム不足が問題とな
っている。牛骨粉はカルシウムとリンの比率が骨のまま
保存されていることから、食した後骨に移行しやすいと
報告されており、特に、800℃以上の高温で焼成し粉
砕した焼成骨粉は未焼成骨粉と比較して苦味が少なく、
食品素材に適しているといわれている。しかし、焼成時
にタンパク質が燃焼するために特有の悪臭が発生し脱臭
等の設備が必要となることから、海外からの輸入製品と
比較してコストが高くなる。したがって、安価かつ苦味
のないカルシウムアパタイトを製造する技術が望まれて
いる。[0004] It has been pointed out that calcium is deficient in Japanese dietary habits. In particular, calcium deficiency in young women has become a problem in relation to osteoporosis. It has been reported that beef bone meal is easily transferred to bone after eating because the ratio of calcium and phosphorus is preserved as bone, and in particular, fired bone powder baked and crushed at a high temperature of 800 ° C or more is unfired. Less bitter than bone meal,
It is said to be suitable for food materials. However, the burning of the protein during the baking produces a peculiar odor and requires equipment for deodorization and the like, so that the cost is higher than products imported from overseas. Therefore, a technique for producing inexpensive and bitter-free calcium apatite is desired.
【0005】[0005]
【発明が解決しようとする課題】本発明の課題は、活性
酸素フリーラジカル消去活性及びアンジオテンシンI変
換酵素阻害作用を有する健康食品に最適な家畜又は魚残
査由来のオリゴペプチド、及び魚類鱗や骨からカルシウ
ムアパタイトを主成分とする白色結晶を簡易かつ低廉に
製造することができる方法を提供することにある。DISCLOSURE OF THE INVENTION An object of the present invention is to provide an oligopeptide derived from livestock or fish residue, which is optimal for health foods having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity, and fish scales and bones To provide a simple and inexpensive method for producing white crystals containing calcium apatite as a main component.
【0006】[0006]
【課題を解決するための手段】本発明者らは、畜産・水
産加工残渣から付加価値を有する物質や素材を簡易かつ
低廉に製造する研究を行う過程で、魚類又は家畜類由来
のコラーゲン又はケラチンをプロテアーゼにより酵素的
加水分解処理すると、活性酸素フリーラジカル消去活性
及びアンジオテンシンI変換酵素阻害作用を有するオリ
ゴペプチドが得られることや、その前処理で得られる魚
類鱗の希酸脱灰処理溶液のpHを中性付近にするとカル
シウムアパタイトを主成分とする白色結晶が得られるこ
とを見い出し、本発明を完成するに至った。Means for Solving the Problems The inventors of the present invention conducted a study on the simple and inexpensive production of value-added substances and raw materials from livestock and fishery processing residues, and found that collagen or keratin derived from fish or livestock. Enzymatic hydrolysis treatment with protease to obtain an oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity, and the pH of a dilute acid demineralization solution of fish scale obtained by the pretreatment. Was set to near neutrality to obtain white crystals containing calcium apatite as a main component, and completed the present invention.
【0007】すなわち本発明は、魚類又は家畜類由来の
コラーゲン又はケラチンをプロテアーゼにより酵素的加
水分解処理することを特徴とする活性酸素フリーラジカ
ル消去活性及びアンジオテンシンI変換酵素阻害作用を
有するオリゴペプチドの製造法(請求項1)や、魚類又
は家畜類由来のコラーゲン又はケラチンが、魚類鱗、魚
及び家畜の骨、家畜の皮由来のコラーゲン、又は豚毛、
フェザーミール、蹄角由来のケラチンであることを特徴
とする請求項1記載の活性酸素フリーラジカル消去活性
及びアンジオテンシンI変換酵素阻害作用を有するオリ
ゴペプチドの製造法(請求項2)や、魚類又は家畜類由
来のコラーゲンが、弱酸性溶液、弱アルカリ性溶液、又
は温水を用いてコラーゲンから高分子のコラーゲンタン
パク質を抽出した抽出残渣であることを特徴とする請求
項1又は2記載の活性酸素フリーラジカル消去活性及び
アンジオテンシンI変換酵素阻害作用を有するオリゴペ
プチドの製造法(請求項3)や、プロテアーゼによる酵
素的加水分解処理に先だって行われる前処理が、脱灰処
理及び/又は脱脂処理であることを特徴とする請求項1
〜3のいずれか記載の活性酸素フリーラジカル消去活性
及びアンジオテンシンI変換酵素阻害作用を有するオリ
ゴペプチドの製造法(請求項4)や、プロテアーゼとし
て、至適反応温度が45〜65℃のバチルス属細菌由来
のアルカリプロテアーゼを用いることを特徴とする請求
項1〜4のいずれか記載の活性酸素フリーラジカル消去
活性及びアンジオテンシンI変換酵素阻害作用を有する
オリゴペプチドの製造法(請求項5)や、請求項1〜5
のいずれか記載の活性酸素フリーラジカル消去活性及び
アンジオテンシンI変換酵素阻害作用を有するオリゴペ
プチドの製造法により製造することができる活性酸素フ
リーラジカル消去活性及びアンジオテンシンI変換酵素
阻害作用を有するオリゴペプチド(請求項6)や、請求
項6記載の活性酸素フリーラジカル消去活性及びアンジ
オテンシンI変換酵素阻害作用を有するオリゴペプチド
を有効成分として含有する機能性食品(請求項7)や、
請求項6記載の活性酸素フリーラジカル消去活性及びア
ンジオテンシンI変換酵素阻害作用を有するオリゴペプ
チドを有効成分とするフリーラジカル起因疾患の予防及
び/又は症状改善剤(請求項8)や、請求項6記載の活
性酸素フリーラジカル消去活性及びアンジオテンシンI
変換酵素阻害作用を有するオリゴペプチドを有効成分と
する高血圧疾患の予防及び/又は症状改善剤(請求項
9)や、魚類鱗又は魚類若しくは家畜類の骨を希酸処理
し、溶解した溶液をアルカリ溶液によりpH5以上と
し、析出する沈殿を分離、水洗することを特徴とするカ
ルシウムアパタイトを主成分とする白色結晶の製造法
(請求項10)に関する。That is, the present invention provides an oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity, which is characterized in that collagen or keratin derived from fish or livestock is enzymatically hydrolyzed with a protease. Method (claim 1), collagen or keratin derived from fish or livestock, fish scales, bones of fish and livestock, collagen derived from livestock skin, or pig hair,
2. The method for producing an oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity according to claim 1, wherein the feather meal is keratin derived from a hoof horn, or a fish or livestock. 3. The active oxygen free radical scavenging according to claim 1 or 2, wherein the collagen derived from the class is an extraction residue obtained by extracting a high molecular weight collagen protein from collagen using a weakly acidic solution, a weakly alkaline solution, or warm water. The method for producing an oligopeptide having an activity and an angiotensin I converting enzyme inhibitory action (Claim 3), and the pretreatment performed prior to the enzymatic hydrolysis treatment with a protease is a decalcification treatment and / or a defatting treatment. Claim 1
4. The method for producing an oligopeptide having an active oxygen free radical-scavenging activity and an angiotensin I converting enzyme inhibitory activity according to any one of claims 3 to 3, and a bacterium belonging to the genus Bacillus having an optimum reaction temperature of 45 to 65 ° C. as a protease. A method for producing an oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity according to any one of claims 1 to 4, wherein an alkaline protease derived from the enzyme is used (claim 5). 1-5
An oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity, which can be produced by the method for producing an oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibiting activity according to any one of claims Item 6) or a functional food containing an oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity according to Claim 6 as an active ingredient (Claim 7),
An agent for preventing and / or ameliorating a disease caused by a free radical, comprising an oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity according to claim 6 (claim 8), and claim 6. Oxygen Free Radical Scavenging Activity of Angiotensin I
An agent for preventing and / or improving symptoms of hypertension, comprising an oligopeptide having a converting enzyme inhibitory activity as an active ingredient (Claim 9), or a solution prepared by diluting a fish scale or fish or livestock bone with a dilute acid and dissolving the solution with an alkali. The present invention relates to a method for producing white crystals containing calcium apatite as a main component, wherein a pH of the solution is adjusted to 5 or more by a solution, and a precipitated precipitate is separated and washed with water.
【0008】[0008]
【発明の実施の形態】本発明の活性酸素フリーラジカル
消去活性及びアンジオテンシンI変換酵素阻害作用を有
するオリゴペプチドの製造法は、魚類又は家畜類由来の
コラーゲン又はケラチンをプロテアーゼにより酵素的加
水分解処理することを特徴とするが、本発明における魚
類又は家畜類由来のコラーゲンとしては、畜産・水産加
工残渣等から得られるコラーゲンを含む物質であれば特
に制限されず、例えば魚類鱗、魚及び家畜の骨、家畜の
皮等由来のコラーゲンを挙げることができる。これらは
新鮮なものでも、乾燥物でもよく、また異なる由来のも
のの混合物でもよい。また、コラーゲンタンパク質は弱
酸、弱アルカリ、温水により高分子のままで抽出するこ
とも可能なことから、魚類鱗、魚及び家畜の骨、家畜の
皮等由来のコラーゲンから、弱酸性溶液、弱アルカリ性
溶液、又は温水を用いて高分子のコラーゲンタンパク質
を抽出した抽出残渣を、本発明における魚類又は家畜類
由来のコラーゲンとすることもできる。BEST MODE FOR CARRYING OUT THE INVENTION The process for producing an oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity according to the present invention comprises subjecting fish or livestock-derived collagen or keratin to enzymatic hydrolysis with a protease. Although it is characterized in that the collagen derived from fish or livestock in the present invention is not particularly limited as long as it is a substance containing collagen obtained from livestock and fishery processing residues, for example, fish scales, fish and livestock bones And collagen derived from the skin of livestock. These may be fresh, dried or a mixture of different origins. In addition, since collagen protein can be extracted as a macromolecule with weak acid, weak alkali, and warm water, it can be extracted from collagen derived from fish scales, fish and livestock bones, livestock skin, etc. The extraction residue obtained by extracting a high molecular weight collagen protein using a solution or hot water can be used as collagen derived from fish or livestock in the present invention.
【0009】本発明における魚類又は家畜類由来のケラ
チンとしては、畜産・水産加工残渣等から得られるケラ
チンを含む物質であれば特に制限されず、例えば豚毛、
家禽毛、フェザーミール、蹄角等由来のケラチンを挙げ
ることができる。これらは新鮮なものでも、乾燥物でも
よく、また異なる由来のものの混合物でもよい。The keratin derived from fish or livestock in the present invention is not particularly limited as long as it is a substance containing keratin obtained from livestock and fishery processing residues.
Keratin derived from poultry hair, feather meal, hoof horn and the like can be mentioned. These may be fresh, dried or a mixture of different origins.
【0010】本発明において、プロテアーゼによる酵素
的加水分解処理に先だって行われる前処理としては、脱
灰処理や脱脂処理を挙げることができ、かかる前処理
は、コラーゲンタンパクを含有する魚鱗、骨、皮と、ケ
ラチンタンパクを含む豚毛、フェザーミール、蹄角では
通常異なる。例えば、魚鱗はカルシウムアパタイトを主
成分とする無機成分が約50%含まれるが脂質含量が1
%以下であるため、希酸溶液による無機成分の溶解すな
わち脱灰処理が望ましく、皮は無機成分含量が少ないが
脂質含量が高いため、ヘキサンやアセトン等による脱脂
処理が望ましく、骨は無機分も脂質も含むため、脱脂と
脱灰の両処理を行うことが望ましい。また、ケラチンタ
ンパクを含有する豚毛、フェザーミール、蹄角はタンパ
ク質含量が高いが構造が強固であるので、加熱処理及び
粉砕を行うことが望ましい。In the present invention, examples of the pretreatment performed prior to the enzymatic hydrolysis treatment with a protease include a decalcification treatment and a defatting treatment, and such pretreatment includes a fish scale, a bone and a skin containing collagen protein. And pig hairs containing keratin proteins, feather meals and hoofs are usually different. For example, a fish scale contains about 50% of an inorganic component mainly composed of calcium apatite, but has a lipid content of 1%.
% Or less, it is desirable to dissolve the inorganic components with a dilute acid solution, that is, demineralize the skin. The skin has a low inorganic component content but a high lipid content. Since it also contains lipids, it is desirable to perform both degreasing and decalcification. Further, pig hair, feather meal, and hoof horn containing keratin protein have a high protein content but a strong structure. Therefore, it is desirable to perform heat treatment and pulverization.
【0011】本発明において、プロテアーゼによる酵素
的加水分解処理は、前記畜産・水産加工残査の種類に適
した前処理を行った後に得られる固形分を基質として通
常行われるが、酵素的加水分解処理するために用いられ
るプロテアーゼとしては、本発明の活性酸素フリーラジ
カル消去活性及びアンジオテンシンI変換酵素阻害作用
を有するオリゴペプチドが得られるものであれば特に制
限されるものではないが、至適反応温度が45〜65℃
のバチルス属細菌由来のアルカリプロテアーゼを用いる
ことが好ましく、またコラーゲンタンパク含有物加水分
解用のプロテアーゼとケラチンタンパク含有物加水分解
用のプロテアーゼとでは、異なるプロテアーゼを用いる
ことが好ましい。そして、酵素的加水分解処理において
は、不溶性基質に酵素が吸着する性質を利用し、反応後
に基質のみを添加した後静置し、可溶化したペプチドを
含む反応上澄液を分離してから水を添加し撹拌を再開す
るという方法で、酵素を繰り返し使用することもでき
る。In the present invention, the enzymatic hydrolysis treatment with a protease is usually carried out using a solid obtained after performing a pretreatment suitable for the type of the above-mentioned livestock and marine processing residue as a substrate. The protease used for the treatment is not particularly limited as long as the oligopeptide having the active oxygen free radical scavenging activity and the angiotensin I converting enzyme inhibitory activity of the present invention can be obtained. Is 45-65 ° C
It is preferable to use an alkaline protease derived from Bacillus bacterium, and it is preferable to use a different protease between a protease for hydrolyzing a collagen protein-containing substance and a protease for hydrolyzing a keratin protein-containing substance. In the enzymatic hydrolysis treatment, utilizing the property that the enzyme is adsorbed on the insoluble substrate, the reaction is performed by adding only the substrate after the reaction, and then allowed to stand.The reaction supernatant containing the solubilized peptide is separated, and then water is added. The enzyme can also be used repeatedly by a method of adding and restarting stirring.
【0012】上記コラーゲンタンパク含有物加水分解用
のプロテアーゼとしては、例えば、バチルス属細菌由来
のアルカリプロテアーゼ「プロレザー」(天野製薬社
製)、アスペルギルス属由来のアルカリ性プロテアーゼ
「スミチームMP」(新日本化学社製)、アスペルギル
ス属由来の酸性プロテアーゼ「スミチームAP」(新日
本化学社製)、アスペルギルス属由来の酸性プロテアー
ゼ「プロチンFA」(大和化成社製)、アスペルギルス
属由来の酸性プロテアーゼ「デナプシン10P」(ナガ
セ生化学工業社製)を挙げることができるが、至適反応
温度60℃、至適反応pH8.0〜8.3である上記バ
チルス属細菌由来のアルカリプロテアーゼ「プロレザ
ー」が分解率等において好ましい。As the protease for hydrolyzing the collagen protein-containing substance, for example, alkaline protease "Proleather" derived from a bacterium belonging to the genus Bacillus (manufactured by Amano Pharmaceutical Co., Ltd.) and alkaline protease "Sumiteam MP" derived from the genus Aspergillus (Shin Nippon Chemical Co., Ltd.) Aspergillus-derived acidic protease "Sumiteam AP" (manufactured by Shin Nippon Chemical Co., Ltd.), Aspergillus-derived acid protease "Protin FA" (Daiwa Kasei Co., Ltd.), Aspergillus-derived acid protease "Denapsin 10P" ( Nagase Seikagaku Kogyo Co., Ltd.). The alkaline protease "Proleather" derived from the bacterium belonging to the genus Bacillus, which has an optimal reaction temperature of 60 ° C. and an optimal reaction pH of 8.0 to 8.3, can be used in the degradation rate and the like. preferable.
【0013】また、上記ケラチンタンパク含有物加水分
解用のプロテアーゼとしては、バチルス属細菌由来のア
ルカリプロテアーゼ「ザビナーゼ」(Savinase; Novo社
製)、バチルス属細菌由来のアルカリプロテアーゼ「エ
スペラーゼ」(Esperase; Novo社製)、バチルス属細菌
由来のアルカリプロテアーゼ「アルカラーゼ」(Alcala
se; Novo社製)を挙げることができるが、至適反応温度
50℃、至適反応pH8.3である上記バチルス属細菌
由来のアルカリプロテアーゼ「ザビナーゼ」が分解率等
において好ましい。As proteases for hydrolyzing the keratin protein-containing substance, alkaline protease "Zavinasase" derived from a bacterium belonging to the genus Bacillus (Savinase; Novo) and alkaline protease "esperase" derived from a bacterium belonging to the genus Bacillus (Esperase; Novo) are used. Co., Ltd.), alkaline protease "Alcalase" derived from Bacillus bacteria (Alcala
se; manufactured by Novo), but the alkaline protease “zabinase” derived from the bacterium belonging to the genus Bacillus, which has an optimum reaction temperature of 50 ° C. and an optimum reaction pH of 8.3, is preferable in terms of the degradation rate and the like.
【0014】本発明において、活性酸素フリーラジカル
消去活性及びアンジオテンシンI変換酵素阻害作用を有
するオリゴペプチドとしては、本発明の活性酸素フリー
ラジカル消去活性及びアンジオテンシンI変換酵素阻害
作用を有するオリゴペプチドの製造法により得られるも
のであればどのようなものでもよく、平均重合度が2〜
5のオリゴペプチドを主成分とするペプチドの混合物を
具体的に例示することができる。アンジオテンシンI変
換酵素阻害作用は、混合ペプチドのうちの特定のアミノ
酸配列を有するペプチドが高い活性を有すると考えられ
るが、活性酸素フリーラジカル消去活性については、す
べてのペプチドが活性を有することから、製造したペプ
チドを食品素材等として使用する場合に、特定のペプチ
ドだけを精製する必要はなく、また、オリゴペプチドの
みに精製する必要もない。したがって、本発明の活性酸
素フリーラジカル消去活性及びアンジオテンシンI変換
酵素阻害作用を有するオリゴペプチドには、活性酸素フ
リーラジカル消去活性及びアンジオテンシンI変換酵素
阻害作用を有するオリゴペプチド含有組成物も含まれ
る。In the present invention, the oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity is a process for producing an oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity according to the present invention. Any one may be used as long as the average degree of polymerization is 2 to 2
Specific examples of the mixture of peptides having the oligopeptide of 5 as a main component can be given. Angiotensin I-converting enzyme inhibitory activity is considered that a peptide having a specific amino acid sequence among the mixed peptides is considered to have a high activity, but the active oxygen free radical scavenging activity is determined because all peptides have an activity. When the peptide thus obtained is used as a food material or the like, it is not necessary to purify only a specific peptide, nor is it necessary to purify only an oligopeptide. Therefore, the oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity of the present invention also includes an oligopeptide-containing composition having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity.
【0015】本発明の活性酸素フリーラジカル消去活性
及びアンジオテンシンI変換酵素阻害作用を有するオリ
ゴペプチドを有効成分として含有する機能性食品におけ
る食品としては、パン、麺類、飲料、総菜、ヨーグル
ト、豆腐などの固形食品、液状食品、半固形状食品等食
品であれば特に制限されることはない。また、本発明の
活性酸素フリーラジカル消去活性及びアンジオテンシン
I変換酵素阻害作用を有するオリゴペプチドを有効成分
とする、フリーラジカル起因疾患や高血圧疾患の予防及
び/又は症状改善剤としては、本発明の上記オリゴペプ
チドに公知の賦形剤等を添加し、常法により予防及び/
又は症状改善剤として調剤したものを例示することがで
きる。The functional food containing the oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity of the present invention as an active ingredient includes breads, noodles, beverages, side dishes, yogurt, tofu and the like. There is no particular limitation on foods such as solid foods, liquid foods, and semi-solid foods. The preventive and / or symptom-ameliorating agent for a free radical-induced disease or a hypertension disease, comprising an oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity of the present invention as an active ingredient, A known excipient or the like is added to the oligopeptide, and prevention and / or
Alternatively, those prepared as a symptom improving agent can be exemplified.
【0016】本発明のカルシウムアパタイトを主成分と
する白色結晶の製造法は、魚類鱗又は魚類若しくは家畜
類の骨を希酸処理し、溶解した溶液をアルカリ溶液によ
りpH5以上とし、析出する沈殿を分離、水洗すること
を特徴とするものであり、かかるカルシウムアパタイト
を主成分とする白色結晶は、前述の前処理における脱灰
処理工程において、魚類鱗あるいは脱脂した骨から希酸
処理により得られるカルシウムアパタイトが希酸に溶解
した溶液のpHをアルカリ溶液を用いて5以上に上げ、
一度溶解したカルシウムアパタイトを白色結晶として再
析出させることにより得ることができる。この白色結晶
はpHを5以上に上げることにより析出するが、カルシ
ウム及びリンの回収率を高めるためにはpH7以上に上
げることが好ましい。本発明のカルシウムアパタイトを
主成分とする白色結晶の製造法は、タンパク質を焼成す
る必要がなく、低廉かつ簡易な方法で悪臭発生を伴うこ
とがないという特徴を有する。According to the method of the present invention for producing white crystals containing calcium apatite as a main component, the scale of fish scales or the bones of fish or livestock is treated with a dilute acid, the dissolved solution is adjusted to pH 5 or more with an alkaline solution, and the precipitated precipitates. Separation, characterized by washing with water, such white crystals mainly composed of calcium apatite, in the decalcification step in the above pretreatment, calcium obtained by dilute acid treatment from fish scales or defatted bone The pH of the solution in which apatite is dissolved in dilute acid is raised to 5 or more using an alkaline solution,
It can be obtained by re-precipitating once dissolved calcium apatite as white crystals. The white crystals are precipitated by raising the pH to 5 or more, but it is preferable to raise the pH to 7 or more in order to increase the recovery of calcium and phosphorus. The method for producing white crystals containing calcium apatite as a main component according to the present invention has a feature that it is not necessary to calcine proteins, and it is a low-cost and simple method and does not generate odor.
【0017】[0017]
【実施例】以下、本発明を実施例によりさらに詳細に説
明するが、本発明はこれら実施例に限定されるものでは
ない。 実施例1 新鮮な魚鱗を、その乾燥重量の10倍量の0.6N塩酸
溶液に24時間浸漬した後、濾過することにより脱灰後
のコラーゲンを主成分とする魚鱗固形分を得た。この固
形分を乾燥重量で62.5g/lとなるように水で希釈
した後撹拌型反応槽に入れ、温度60℃、pH8.0に
設定した後、タンパク質濃度として0.0625g/l
のバチルス属細菌由来のアルカリプロテアーゼ「プロレ
ザー」(天野製薬社製)を添加し、1時間酵素処理を行
った。この酵素処理により、固形分の95%以上が分解
され、可溶化していた。固形分を除去した酵素処理液を
凍結乾燥し、酵素的加水分解オリゴペプチドの乾燥物を
得た。トリニトロベンゼンスルホン酸法により求めた、
このオリゴペプチド乾燥物のアミノ酸の平均重合度は2
から5であった。このオリゴペプチド乾燥物の活性酸素
フリーラジカル消去活性をルミノール依存性化学発光法
により測定したところ、ラジカルの発生量を50%抑制
するIPOX50は1〜3mg/mlであり、明確な活性
酸素フリーラジカル消去活性を有していた。また、アン
ジオテンシンI変換酵素阻害作用を調べたところ、アン
ジオテンシンI変換酵素活性を50%に抑制するのに必
要な濃度IC50は約5mg/mlであり、同活性を有す
ることが報告されている鰯と同程度の活性を有してい
た。EXAMPLES Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples. Example 1 Fresh fish scales were immersed in a 0.6N hydrochloric acid solution 10 times the dry weight for 24 hours, and then filtered to obtain fish scale solids mainly containing collagen after decalcification. After diluting this solid content with water so as to have a dry weight of 62.5 g / l, the solution was put into a stirred reaction tank, and the temperature was set to 60 ° C. and the pH was set to 8.0, and then the protein concentration was 0.0625 g / l.
Was added, and an alkaline protease "Proleather" (manufactured by Amano Pharmaceutical Co., Ltd.) derived from Bacillus sp. By this enzyme treatment, 95% or more of the solid content was decomposed and solubilized. The enzyme-treated solution from which solids had been removed was freeze-dried to obtain a dried enzymatically hydrolyzed oligopeptide. Determined by the trinitrobenzenesulfonic acid method,
The average degree of polymerization of amino acids in the dried oligopeptide is 2
From 5. When the active oxygen free radical scavenging activity of the dried oligopeptide was measured by a luminol-dependent chemiluminescence method, the IPOX 50 that suppressed the amount of generated radicals by 50% was 1 to 3 mg / ml. It had erasing activity. When the inhibitory effect on angiotensin I converting enzyme was examined, the concentration IC 50 required to suppress the activity of angiotensin I converting enzyme to 50% was about 5 mg / ml, and sardines reported to have the same activity were reported. Had the same level of activity as
【0018】実施例2 実施例1で得られる脱灰後のコラーゲンを主成分とする
魚鱗固形分を用い、ガラス製ビーカー中でpH3の酸性
条件下で125g/l、温度60℃でときどき攪拌しな
がら1時間酸可溶性タンパク質を抽出した。濾過により
抽出残渣とタンパク抽出液とを分離し、抽出残渣を基質
とし、基質濃度62.5g/l、タンパク質濃度として
0.0625g/lのバチルス属細菌由来のアルカリプ
ロテアーゼ「プロレザー」(天野製薬社製)、温度60
℃、pH8.0の条件で1時間酵素分解することによ
り、平均重合度2〜5のオリゴペプチドを得た。このオ
リゴペプチドの活性酸素フリーラジカル消去活性はIP
OX50で約2mg/ml、アンジオテンシンI変換酵素
活性はIC50で約5mg/mlであった。これらの結果
から、タンパク抽出操作を行わずに直接酵素分解した魚
鱗サンプルと同様のオリゴペプチドが得られることがわ
かった。Example 2 The descaled fish scale solids obtained in Example 1 and containing collagen as a main component were stirred occasionally at 125 g / l at a temperature of 60 ° C. under acidic conditions of pH 3 in a glass beaker. The acid-soluble protein was extracted for 1 hour while heating. An extraction residue and a protein extract are separated by filtration, and the extraction residue is used as a substrate. The alkaline protease "Proleather" derived from Bacillus bacteria having a substrate concentration of 62.5 g / l and a protein concentration of 0.0625 g / l (Amano Pharmaceutical Co., Ltd.) Company), temperature 60
An oligopeptide having an average degree of polymerization of 2 to 5 was obtained by enzymatic decomposition for 1 hour at a temperature of 8.0 ° C. and pH 8.0. The active oxygen free radical scavenging activity of this oligopeptide is IP
About 2mg / ml in OX 50, angiotensin I converting enzyme activity was about 5 mg / ml in IC 50. From these results, it was found that the same oligopeptide as the fish scale sample directly enzymatically degraded without performing the protein extraction operation was obtained.
【0019】実施例3 新鮮な豚皮を用い、アセトンを溶媒としてロータリーエ
バポレーター中で150g/lの濃度で室温条件下24
時間ゆっくり回転させながら脱脂した。濾過によりアセ
トンを除去した後、ロータリーエバポレーターを用いて
アセトンを完全に除去した。得られた脱脂豚皮をボーン
チョッパーで粗粉砕し、ロータリーエバポレーター中で
pH3の酸性条件下で125g/l、温度60℃で1時
間ゆっくり回転させながら酸可溶性タンパク質の抽出を
行った後、濾過により抽出残査とタンパク抽出液を分離
し、この抽出残査を基質として、基質濃度62.5g/
l、タンパク質濃度として0.78g/lのバチルス属
細菌由来のアルカリプロテアーゼ「プロレザー」(天野
製薬社製)、温度60℃、pH8.0の条件で1時間酵
素分解することにより、平均重合度2〜4のオリゴペプ
チドを得た。このオリゴペプチドの活性酸素フリーラジ
カル消去活性はIPOX50で約2〜5mg/ml、アン
ジオテンシンI変換酵素活性はIC50で約5〜9mg/
mlであった。なお、前記タンパク抽出液を凍結乾燥し
て乾燥物を得、含まれるタンパク質の分子量をSDS−
ポリアクリルアミド電気泳動法により調べた結果、主と
して100,000Da以上の高分子タンパク質であっ
た。また、全有機炭素濃度で約70g/lとなるように
調製した溶液に対して示差走査熱量計により結合水と自
由水の割合を調べた結果、すべての水が結合水であり、
得られたタンパク質は保水性に優れていた。Example 3 Fresh pork skin was used in a rotary evaporator at a concentration of 150 g / l using acetone as a solvent in a rotary evaporator under room temperature conditions.
Degreasing while rotating slowly for hours. After removing acetone by filtration, acetone was completely removed using a rotary evaporator. The resulting defatted pork skin is coarsely ground with a bone chopper, and the acid-soluble protein is extracted while rotating slowly at 125 g / l at a temperature of 60 ° C. for 1 hour under acidic conditions of pH 3 in a rotary evaporator, followed by filtration. The extraction residue and the protein extract were separated, and the extraction residue was used as a substrate, and the substrate concentration was 62.5 g /
1. The average degree of polymerization of Bacillus bacterium-derived alkaline protease "Proleather" (manufactured by Amano Pharmaceutical Co., Ltd.) with a protein concentration of 0.78 g / l, at 60 ° C. and pH 8.0 for 1 hour. Two to four oligopeptides were obtained. Active oxygen free radical scavenging activity of the oligopeptides of about 2-5 mg / ml in IPOX 50, with angiotensin I converting enzyme activity the IC 50 of about 5~9Mg /
ml. The protein extract was freeze-dried to obtain a dried product, and the molecular weight of the contained protein was determined by SDS-
As a result of examination by polyacrylamide electrophoresis, it was mainly a high molecular weight protein of 100,000 Da or more. Further, as a result of examining the ratio of bound water and free water by a differential scanning calorimeter to a solution prepared so as to have a total organic carbon concentration of about 70 g / l, all water was bound water,
The obtained protein was excellent in water retention.
【0020】実施例4 レンダリング会社で肥料や飼料として製造されている、
コラーゲンを含有しているミートミール、魚粉、牛骨及
びケラチンを含有しているフェザーミールを、熱処理及
び脱脂処理を行うことなく酵素処理を行った。コラーゲ
ン系の酵素処理条件は、基質濃度62.5g/l、タン
パク質濃度として0.78g/lのバチルス属細菌由来
のアルカリプロテアーゼ「プロレザー」(天野製薬社
製)、温度60℃、pH8.0の条件で3時間酵素分解
することにより、また、ケラチン系の酵素処理条件は、
基質濃度62.5g/l、タンパク質濃度として0.1
6〜0.31g/lのバチルス属細菌由来のアルカリプ
ロテアーゼ「ザビナーゼ」(Savinase; Novo社製)、温
度50℃、pH8.3の条件で1時間酵素分解すること
により種々の酵素分解オリゴペプチドを得た。得られた
これらオリゴペプチドの平均重合度は2〜4であり、活
性酸素フリーラジカル消去活性はIPOX50で0.35
〜3mg/ml(豚皮;1〜3mg/ml、魚鱗;2〜
3mg/ml、フェザーミール;1.25mg/ml、
牛骨;0.8mg/ml、蹄角;0.35mg/m
l)、アンジオテンシンI変換酵素活性はIC50で1〜
3mg/mlであった。Example 4 Manufactured as a fertilizer or feed by a rendering company.
Meatmeal containing collagen, fishmeal, beef bone, and feather meal containing keratin were subjected to enzyme treatment without heat treatment and degreasing treatment. The conditions of collagen-based enzyme treatment were as follows: Bacillus-derived alkaline protease “Proleather” (manufactured by Amano Pharmaceutical Co., Ltd.) having a substrate concentration of 62.5 g / l and a protein concentration of 0.78 g / l, a temperature of 60 ° C., and a pH of 8.0. By enzymatic decomposition for 3 hours, the keratin-based enzyme treatment conditions are as follows:
Substrate concentration 62.5 g / l, protein concentration 0.1
6 to 0.31 g / l of an alkaline protease derived from a bacterium belonging to the genus Bacillus “Savinase” (manufactured by Novo), which is enzymatically degraded for 1 hour at a temperature of 50 ° C. and a pH of 8.3 to produce various enzymatically degraded oligopeptides. Obtained. The average degree of polymerization of the obtained oligopeptides is 2 to 4, and the active oxygen free radical scavenging activity is 0.35 in IPOX 50 .
~ 3mg / ml (pig skin; 1-3mg / ml, fish scale;
3 mg / ml, feather meal; 1.25 mg / ml,
Beef bone: 0.8 mg / ml, hoof angle: 0.35 mg / m
l), angiotensin I converting enzyme activity 1 with an IC 50
It was 3 mg / ml.
【0021】実施例5 実施例1で得られた脱灰液のpHを1N水酸化ナトリウ
ム水溶液で7以上に上げることにより白色沈殿を析出さ
せた。得られた沈殿をろ過した後、塩酸溶液と同量の蒸
留水で洗浄した。図1には上記pH7で析出させた白色
結晶のFT−IRスペクトルを、図2には標準試薬であ
るカルシウムアパタイト(和光純薬工業社製「試薬特級
アパタイトHAP, 単結晶」)のFT−IRスペクトル
を、及び図3には標準試薬であるリン酸カルシウム(和
光純薬工業社製「試薬特級リン酸三カルシウム」)のF
T−IRスペクトルをそれぞれ示す。図1〜3からわか
るように、上記白色結晶のスペクトルには、カルシウム
アパタイトの特徴を有するOH伸縮振動が3,400〜
3,500cm-1付近に見られ、さらに指紋領域に入っ
ている400〜1,800cm-1のスペクトルがリン酸
カルシウムではなくてカルシウムアパタイトに類似して
いることから、得られた白色結晶はカルシウムアパタイ
トであると考えられる。ところで、脱灰液中にはカルシ
ウムイオンとリン酸イオンが存在するが、pHを7に上
げることによりリン酸カルシウムではなくてカルシウム
アパタイトが析出したことが示された。Example 5 A white precipitate was deposited by raising the pH of the demineralized solution obtained in Example 1 to 7 or more with a 1N aqueous sodium hydroxide solution. After the obtained precipitate was filtered, the precipitate was washed with the same amount of distilled water as the hydrochloric acid solution. FIG. 1 shows the FT-IR spectrum of the white crystal precipitated at the above pH 7, and FIG. 2 shows the FT-IR spectrum of calcium apatite (reagent special grade apatite HAP, single crystal, manufactured by Wako Pure Chemical Industries) as a standard reagent. FIG. 3 shows the spectrum of F of calcium phosphate (reagent special grade tricalcium phosphate manufactured by Wako Pure Chemical Industries, Ltd.) as a standard reagent.
Each T-IR spectrum is shown. As can be seen from FIGS. 1 to 3, the spectrum of the white crystal has an OH stretching vibration having a characteristic of calcium apatite of 3,400 to 3,400.
3,500cm observed at about -1, since the spectrum of 400~1,800Cm -1, further enters the fingerprint area is similar to calcium apatite rather than calcium phosphate, obtained in white crystals of calcium apatite It is believed that there is. By the way, although calcium ions and phosphate ions were present in the demineralized solution, it was shown that calcium apatite instead of calcium phosphate was precipitated by raising the pH to 7.
【0022】[0022]
【発明の効果】本発明によると、処理に困っている廃棄
物等から付加価値の高い素材である、活性酸素フリーラ
ジカル消去活性及びアンジオテンシンI変換酵素阻害作
用を有する健康食品に最適な家畜又は魚残査由来のオリ
ゴペプチドや、魚類鱗や骨からカルシウムアパタイトを
主成分とする白色結晶を簡易低廉に製造することがで
き、工業的にも極めて有効である。According to the present invention, livestock or fish optimal for health foods having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity, which are high value-added materials from wastes and the like which are difficult to treat. White crystals containing calcium apatite as a main component can be easily and inexpensively produced from oligopeptides derived from residues and fish scales and bones, which is extremely effective industrially.
【図1】本発明のカルシウムアパタイトの白色結晶のF
T−IRスペクトルを示す図である。FIG. 1 shows the F of white crystals of calcium apatite of the present invention.
It is a figure which shows a T-IR spectrum.
【図2】標準試薬であるカルシウムアパタイトのFT−
IRスペクトルを示す図である。FIG. 2. FT- of calcium apatite as a standard reagent
It is a figure which shows an IR spectrum.
【図3】標準試薬であるリン酸カルシウムのFT−IR
スペクトルを示す図である。FIG. 3. FT-IR of calcium phosphate as a standard reagent
It is a figure showing a spectrum.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) C01B 25/32 C07K 4/12 C07K 4/12 A61K 37/02 Fターム(参考) 4B018 MD04 MD20 MD22 MD69 MD73 MD74 ME04 ME06 MF10 MF12 4B064 AG01 AG21 BG01 BG09 CA21 CC03 CC06 CD20 CD21 DA01 DA06 4C084 AA02 AA06 AA07 BA43 CA59 DC40 MA52 ZA422 ZC202 ZC412 4H045 AA10 AA20 AA30 CA40 DA57 EA23 FA16 FA70 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) C01B 25/32 C07K 4/12 C07K 4/12 A61K 37/02 F-term (Reference) 4B018 MD04 MD20 MD22 MD69 MD73 MD74 ME04 ME06 MF10 MF12 4B064 AG01 AG21 BG01 BG09 CA21 CC03 CC06 CD20 CD21 DA01 DA06 4C084 AA02 AA06 AA07 BA43 CA59 DC40 MA52 ZA422 ZC202 ZC412 4H045 AA10 AA20 AA30 CA40 DA57 EA23 FA16 FA70
Claims (10)
ラチンをプロテアーゼにより酵素的加水分解処理するこ
とを特徴とする活性酸素フリーラジカル消去活性及びア
ンジオテンシンI変換酵素阻害作用を有するオリゴペプ
チドの製造法。1. A method for producing an oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity, wherein collagen or keratin derived from fish or livestock is enzymatically hydrolyzed with a protease.
ラチンが、魚類鱗、魚及び家畜の骨、家畜の皮由来のコ
ラーゲン、又は豚毛、フェザーミール、蹄角由来のケラ
チンであることを特徴とする請求項1記載の活性酸素フ
リーラジカル消去活性及びアンジオテンシンI変換酵素
阻害作用を有するオリゴペプチドの製造法。2. The collagen or keratin derived from fish or livestock is a fish scale, a bone derived from fish and livestock, a collagen derived from livestock skin, or a keratin derived from pig hair, feather meal, or hoof horn. The method for producing an oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity according to claim 1.
酸性溶液、弱アルカリ性溶液、又は温水を用いてコラー
ゲンから高分子のコラーゲンタンパク質を抽出した抽出
残渣であることを特徴とする請求項1又は2記載の活性
酸素フリーラジカル消去活性及びアンジオテンシンI変
換酵素阻害作用を有するオリゴペプチドの製造法。3. The collagen derived from fish or livestock is an extraction residue obtained by extracting a high molecular weight collagen protein from collagen using a weakly acidic solution, a weakly alkaline solution, or warm water. 2. The method for producing an oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity according to 2.
に先だって行われる前処理が、脱灰処理及び/又は脱脂
処理であることを特徴とする請求項1〜3のいずれか記
載の活性酸素フリーラジカル消去活性及びアンジオテン
シンI変換酵素阻害作用を有するオリゴペプチドの製造
法。4. The scavenging treatment for active oxygen free radicals according to claim 1, wherein the pretreatment carried out prior to the enzymatic hydrolysis treatment with a protease is a decalcification treatment and / or a degreasing treatment. A method for producing an oligopeptide having an activity and an angiotensin I converting enzyme inhibitory action.
5〜65℃のバチルス属細菌由来のアルカリプロテアー
ゼを用いることを特徴とする請求項1〜4のいずれか記
載の活性酸素フリーラジカル消去活性及びアンジオテン
シンI変換酵素阻害作用を有するオリゴペプチドの製造
法。5. The protease has an optimum reaction temperature of 4
The method for producing an oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibiting activity according to any one of claims 1 to 4, wherein an alkaline protease derived from Bacillus bacterium at 5 to 65 ° C is used.
フリーラジカル消去活性及びアンジオテンシンI変換酵
素阻害作用を有するオリゴペプチドの製造法により製造
することができる活性酸素フリーラジカル消去活性及び
アンジオテンシンI変換酵素阻害作用を有するオリゴペ
プチド。6. An active oxygen free radical scavenging activity and angiotensin I which can be produced by the method for producing an oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity according to any one of claims 1 to 5. An oligopeptide having a converting enzyme inhibitory action.
消去活性及びアンジオテンシンI変換酵素阻害作用を有
するオリゴペプチドを有効成分として含有する機能性食
品。7. A functional food containing the oligopeptide having an active oxygen free radical scavenging activity and an angiotensin I converting enzyme inhibitory activity according to claim 6 as an active ingredient.
消去活性及びアンジオテンシンI変換酵素阻害作用を有
するオリゴペプチドを有効成分とするフリーラジカル起
因疾患の予防及び/又は症状改善剤。8. A preventive and / or symptom-ameliorating agent for a free radical-induced disease, comprising an oligopeptide having the active oxygen free radical scavenging activity and the angiotensin I converting enzyme inhibitory activity according to claim 6 as an active ingredient.
消去活性及びアンジオテンシンI変換酵素阻害作用を有
するオリゴペプチドを有効成分とする高血圧疾患の予防
及び/又は症状改善剤。9. A preventive and / or symptom-ameliorating agent for hypertension comprising an oligopeptide having an active oxygen free radical-scavenging activity and an angiotensin I converting enzyme inhibitory activity according to claim 6 as an active ingredient.
希酸処理し、溶解した溶液をアルカリ溶液によりpH5
以上とし、析出する沈殿を分離、水洗することを特徴と
するカルシウムアパタイトを主成分とする白色結晶の製
造法。10. The scale of fish scales or bones of fish or livestock is treated with a dilute acid, and the dissolved solution is adjusted to pH 5 with an alkaline solution.
A method for producing a white crystal containing calcium apatite as a main component, wherein the precipitated precipitate is separated and washed with water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000027588A JP2001211895A (en) | 2000-02-04 | 2000-02-04 | Method of producing physiologically active peptide |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000027588A JP2001211895A (en) | 2000-02-04 | 2000-02-04 | Method of producing physiologically active peptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2001211895A true JP2001211895A (en) | 2001-08-07 |
Family
ID=18553138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000027588A Pending JP2001211895A (en) | 2000-02-04 | 2000-02-04 | Method of producing physiologically active peptide |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001211895A (en) |
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003192566A (en) * | 2001-12-27 | 2003-07-09 | Nonogawa Shoji Kk | Cosmetic |
| JP2004308063A (en) * | 2003-04-08 | 2004-11-04 | Taiki:Kk | Sanitary processed textile products and method for producing the same |
| JP2005534340A (en) * | 2002-07-29 | 2005-11-17 | アミノテック アーエス | Method for recovering peptides / amino acids and oils / fat from raw materials containing one or more proteins, products produced by the method, and use of the products |
| KR100532153B1 (en) * | 2003-06-16 | 2005-11-30 | 주식회사 이제 | producing method of protein hydrolysates from fish scale |
| JP2006166807A (en) * | 2004-12-16 | 2006-06-29 | Takafumi Ishikawa | Health and beauty food |
| JP2006188810A (en) * | 2006-02-16 | 2006-07-20 | Taiki:Kk | Sanitized textile products |
| JP2006306819A (en) * | 2005-05-02 | 2006-11-09 | Kenji Nakamura | Sheetlike cosmetic |
| JP2006342107A (en) * | 2005-06-09 | 2006-12-21 | Nitta Gelatin Inc | Cosmetic composition containing collagen peptide and method for producing the same |
| JP2006348050A (en) * | 2006-09-20 | 2006-12-28 | Shirako:Kk | Medicine for promoting blood flow by vasodilation and health food composition |
| JP2007176909A (en) * | 2005-12-28 | 2007-07-12 | Rich Beauty Science:Kk | Method for producing collagen and low molecular weight collagen |
| CN100370033C (en) * | 2005-10-19 | 2008-02-20 | 由守谊 | A kind of fish scale collagen production process |
| JP2008231065A (en) * | 2007-03-23 | 2008-10-02 | Chisso Corp | Bone metabolism improver |
| JP2009107854A (en) * | 2007-10-26 | 2009-05-21 | Rbs:Kk | Method for producing hydroxyapatite and hydroxyapatite |
| US8241671B2 (en) | 2007-10-26 | 2012-08-14 | RBS Co., Inc. | Biocompatible material and process for manufacturing the same |
| JP2014023449A (en) * | 2012-07-25 | 2014-02-06 | Unitika Ltd | Production method of sulfur-containing cysteine compound |
| JP2015182901A (en) * | 2014-03-20 | 2015-10-22 | 国立大学法人 香川大学 | hydroxyapatite derived from fish bone |
| JP2020505442A (en) * | 2017-01-31 | 2020-02-20 | ケラメディックス インクKeramedix Inc. | Injectable composition for preventing hair loss or promoting hair growth |
| CN118384054A (en) * | 2024-06-07 | 2024-07-26 | 广州伊尔美生物科技有限公司 | Oligopeptide-215 repairing freeze-dried powder and preparation method thereof |
| CN118680296A (en) * | 2024-08-26 | 2024-09-24 | 浙江衡美健康科技股份有限公司 | Composition for increasing skin elasticity and improving skin condition, preparation method and application thereof |
-
2000
- 2000-02-04 JP JP2000027588A patent/JP2001211895A/en active Pending
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003192566A (en) * | 2001-12-27 | 2003-07-09 | Nonogawa Shoji Kk | Cosmetic |
| JP2005534340A (en) * | 2002-07-29 | 2005-11-17 | アミノテック アーエス | Method for recovering peptides / amino acids and oils / fat from raw materials containing one or more proteins, products produced by the method, and use of the products |
| JP2004308063A (en) * | 2003-04-08 | 2004-11-04 | Taiki:Kk | Sanitary processed textile products and method for producing the same |
| KR100532153B1 (en) * | 2003-06-16 | 2005-11-30 | 주식회사 이제 | producing method of protein hydrolysates from fish scale |
| JP2006166807A (en) * | 2004-12-16 | 2006-06-29 | Takafumi Ishikawa | Health and beauty food |
| JP2006306819A (en) * | 2005-05-02 | 2006-11-09 | Kenji Nakamura | Sheetlike cosmetic |
| JP2006342107A (en) * | 2005-06-09 | 2006-12-21 | Nitta Gelatin Inc | Cosmetic composition containing collagen peptide and method for producing the same |
| CN100370033C (en) * | 2005-10-19 | 2008-02-20 | 由守谊 | A kind of fish scale collagen production process |
| JP2007176909A (en) * | 2005-12-28 | 2007-07-12 | Rich Beauty Science:Kk | Method for producing collagen and low molecular weight collagen |
| JP2006188810A (en) * | 2006-02-16 | 2006-07-20 | Taiki:Kk | Sanitized textile products |
| JP2006348050A (en) * | 2006-09-20 | 2006-12-28 | Shirako:Kk | Medicine for promoting blood flow by vasodilation and health food composition |
| JP2008231065A (en) * | 2007-03-23 | 2008-10-02 | Chisso Corp | Bone metabolism improver |
| JP2009107854A (en) * | 2007-10-26 | 2009-05-21 | Rbs:Kk | Method for producing hydroxyapatite and hydroxyapatite |
| US8241671B2 (en) | 2007-10-26 | 2012-08-14 | RBS Co., Inc. | Biocompatible material and process for manufacturing the same |
| US8409622B2 (en) | 2007-10-26 | 2013-04-02 | Rbs Co., Ltd. | Process for manufacturing biocompatible material |
| JP2014023449A (en) * | 2012-07-25 | 2014-02-06 | Unitika Ltd | Production method of sulfur-containing cysteine compound |
| JP2015182901A (en) * | 2014-03-20 | 2015-10-22 | 国立大学法人 香川大学 | hydroxyapatite derived from fish bone |
| JP2020505442A (en) * | 2017-01-31 | 2020-02-20 | ケラメディックス インクKeramedix Inc. | Injectable composition for preventing hair loss or promoting hair growth |
| CN118384054A (en) * | 2024-06-07 | 2024-07-26 | 广州伊尔美生物科技有限公司 | Oligopeptide-215 repairing freeze-dried powder and preparation method thereof |
| CN118680296A (en) * | 2024-08-26 | 2024-09-24 | 浙江衡美健康科技股份有限公司 | Composition for increasing skin elasticity and improving skin condition, preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001211895A (en) | Method of producing physiologically active peptide | |
| CN103230020B (en) | Preparation method of protein short peptide chelated calcium | |
| JP4236850B2 (en) | Method for producing fish-derived collagen peptide, and food and drink and cosmetics containing fish-derived collagen peptide obtained by the method | |
| CN101418328A (en) | Method for producing fish scale collagen protein | |
| KR100699324B1 (en) | Method for producing young protein hydrolyzate | |
| US6342252B1 (en) | Process for producing a bio-organic calcium composition and nutrient agent containing the same | |
| KR20140122532A (en) | A method for extracting high purity collagen from animal byproducts | |
| Pateiro et al. | Extraction of valuable compounds from meat by-products | |
| US7297512B2 (en) | Method for producing amino acid components by enzymatic hydrolysis of fish egg skin | |
| US5897881A (en) | Hard tissue intactly dissolved materials and method for producing the same | |
| JP2003245055A (en) | Food composition for skin improvement and skin improvement method | |
| JP2003284586A (en) | Method for producing collagen peptide and method for producing product utilizing the same | |
| CN1291032C (en) | Enzymolysis method for preparing protein oligopeptide powder using Pacific Ocean alaska pollack | |
| WO2006101301A1 (en) | Calcium binding amino acid | |
| JP6143218B2 (en) | Tendon and ligament function improving agent and pharmaceutical composition, food and feed containing the same | |
| JPH09187226A (en) | Protein composition derived from sesame seed and its use | |
| KR102743575B1 (en) | Manufacturing Method of Low Molecular Collagen Peptide Using Fish By-products | |
| JP3651878B2 (en) | Antihypertensive peptide derived from meat protein | |
| JP4790325B2 (en) | Antihypertensive peptide derived from meat protein | |
| Sandhu et al. | Conversion of Bone to Edible Products | |
| RU2562581C1 (en) | Method of producing biologically active agent from sea cucumber, having general tonic and immunomodulating properties | |
| JP2004083451A (en) | Skin lotion | |
| KR20120102600A (en) | Fat accumulation suppressor | |
| Jain et al. | Bioprocessing of Chicken Meat and Egg Processing Industries' Waste to Value‐Added Proteins and Peptides | |
| JPH10215809A (en) | Manufacture of fermented seasoning |